• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGF-β1 通过上调 DDR1 和交联胶原 I 促进肝癌细胞线性侵入小体的形成。

TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking.

机构信息

Mohammed 6 University of health Sciences (UM6SS), Faculty of Medicine, National Laboratory of Reference, Casablanca, Morocco.

INSERM, U1053 Bordeaux Research In Translational Oncology, BaRITOn, F-33000 Bordeaux, France; Univ. Bordeaux, U1053 Bordeaux Research In Translational Oncology, BaRITOn, F-33000 Bordeaux, France.

出版信息

Eur J Cell Biol. 2016 Nov;95(11):503-512. doi: 10.1016/j.ejcb.2016.09.003. Epub 2016 Oct 4.

DOI:10.1016/j.ejcb.2016.09.003
PMID:27720259
Abstract

Transforming growth factor-β1 (TGF-β1) is an important player in chronic liver diseases inducing fibrogenesis and hepatocellular carcinoma (HCC) development. TGF-β1 promotes pleiotropic modifications at the cellular and matrix microenvironment levels. TGF-β1 was described to enhance production of type I collagen and its associated cross-linking enzyme, the lysyl oxidase-like2 (LOXL2). In addition, TGF-β1 and type I collagen are potent inducers of invadosomes. Indeed, type I collagen fibers induce the formation of active linear invadosomes through the discoidin domain receptor 1 (DDR1). The goal of our study was to address the role of TGF-β1 in collagen cross-linking and its impact on the formation of linear invadosomes in liver cancer cells. We first report a significant correlation between expressions of TGF-β1, and type I collagen, LOXL2, DDR1 and MT1-MMP in human HCCs. We demonstrate that TGF-β1 promotes a Smad4-dependent up-regulation of DDR1, together with LOXL2, in cultured HCC cells. Moreover, we show that LOXL2-induced collagen cross-linking enhances linear invadosome formation. Altogether, our data demonstrate that TGF-β1 favors linear invadosome formation through the expressions of both the inducers, such as collagen and LOXL2, and the components such as DDR1 and MT1-MMP of linear invadosomes in cancer cells. Meanwhile, our data uncover a new TGF-β1-dependent regulation of DDR1 expression.

摘要

转化生长因子-β1(TGF-β1)是一种在慢性肝脏疾病中诱导纤维化和肝细胞癌(HCC)发展的重要因子。TGF-β1 在细胞和基质微环境水平上促进多效性修饰。TGF-β1 被描述为增强 I 型胶原及其相关交联酶赖氨酰氧化酶样 2(LOXL2)的产生。此外,TGF-β1 和 I 型胶原是侵袭小体的有效诱导剂。事实上,I 型胶原纤维通过 discoidin 域受体 1(DDR1)诱导活性线性侵袭小体的形成。我们研究的目的是探讨 TGF-β1 在胶原交联中的作用及其对肝癌细胞中线性侵袭小体形成的影响。我们首先报告了 TGF-β1 与 I 型胶原、LOXL2、DDR1 和 MT1-MMP 在人 HCC 中的表达之间存在显著相关性。我们证明 TGF-β1 在培养的 HCC 细胞中促进 Smad4 依赖性上调 DDR1,以及 LOXL2。此外,我们表明 LOXL2 诱导的胶原交联增强了线性侵袭小体的形成。总之,我们的数据表明,TGF-β1 通过诱导物(如胶原和 LOXL2)和线性侵袭小体的成分(如 DDR1 和 MT1-MMP)的表达,促进癌细胞中线性侵袭小体的形成。同时,我们的数据揭示了 TGF-β1 对 DDR1 表达的一种新的依赖性调节。

相似文献

1
TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking.TGF-β1 通过上调 DDR1 和交联胶原 I 促进肝癌细胞线性侵入小体的形成。
Eur J Cell Biol. 2016 Nov;95(11):503-512. doi: 10.1016/j.ejcb.2016.09.003. Epub 2016 Oct 4.
2
Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42-Tuba pathway.Discoidin domain receptor 1 通过 Cdc42-Tuba 通路控制线性侵入小体的形成。
J Cell Biol. 2014 Nov 24;207(4):517-33. doi: 10.1083/jcb.201404079.
3
Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells.年龄相关的 I 型胶原改变会损害非浸润性乳腺癌细胞中 DDR1 诱导的细胞凋亡。
Cell Adh Migr. 2018;12(4):335-347. doi: 10.1080/19336918.2018.1472182. Epub 2018 Jun 28.
4
Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma.细胞外基质重塑激活跨膜受体酪氨酸激酶 DDR1-STAT3 级联反应促进葡萄膜黑色素瘤肝转移定植。
Signal Transduct Target Ther. 2021 May 12;6(1):176. doi: 10.1038/s41392-021-00563-x.
5
Inhibition of DDR1 reduces invasive features of human A375 melanoma, HT29 colon carcinoma and SK-HEP hepatoma cells.抑制 DDR1 可降低人 A375 黑色素瘤、HT29 结肠癌细胞和 SK-HEP 肝癌细胞的侵袭特性。
Cell Adh Migr. 2020 Dec;14(1):69-81. doi: 10.1080/19336918.2020.1733892.
6
Substrate stiffness promotes latent TGF-β1 activation in hepatocellular carcinoma.基质硬度促进肝细胞癌中潜伏性转化生长因子-β1的激活。
Biochem Biophys Res Commun. 2017 Jan 29;483(1):553-558. doi: 10.1016/j.bbrc.2016.12.107. Epub 2016 Dec 24.
7
Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.调控 TGF-β1-CD147 自我维持网络在肝癌细胞分化可塑性中的作用。
Oncogene. 2016 Oct 20;35(42):5468-5479. doi: 10.1038/onc.2016.89. Epub 2016 Apr 4.
8
Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.RIG-I 缺陷型干性高的人肝癌细胞中激活的 TGF-β/Akt/Smad2 信号诱导免疫耐受树突状细胞。
BMC Cancer. 2019 May 14;19(1):439. doi: 10.1186/s12885-019-5670-9.
9
Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.赖氨酰氧化酶样蛋白4是转化生长因子β1(TGF-β1)信号通路的一个新靶基因,它能够负向调节TGF-β1诱导的PLC/PRF/5肝癌细胞的迁移。
Biochem Biophys Res Commun. 2008 Sep 5;373(4):521-7. doi: 10.1016/j.bbrc.2008.06.071. Epub 2008 Jun 27.
10
Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.沉默调节蛋白6通过抑制细胞衰老促进转化生长因子-β1/H2O2/次氯酸介导的肝癌细胞致瘤性增强。
Cancer Sci. 2015 May;106(5):559-66. doi: 10.1111/cas.12632. Epub 2015 Mar 9.

引用本文的文献

1
Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies.癌症转移中的侵袭性伪足:动力学、调控及靶向治疗
J Transl Med. 2025 May 16;23(1):548. doi: 10.1186/s12967-025-06526-y.
2
Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges.上皮-间质转化调控肿瘤微环境:当前认知与挑战
J Transl Med. 2025 Apr 2;23(1):386. doi: 10.1186/s12967-025-06422-5.
3
The dual role of LOXL4 in the pathogenesis and development of human malignant tumors: a narrative review.赖氨酰氧化酶样蛋白4(LOXL4)在人类恶性肿瘤发病机制及发展中的双重作用:一篇综述
Transl Cancer Res. 2024 Apr 30;13(4):2026-2042. doi: 10.21037/tcr-23-2003. Epub 2024 Apr 17.
4
Macrophages and platelets in liver fibrosis and hepatocellular carcinoma.巨噬细胞和血小板在肝纤维化和肝细胞癌中的作用。
Front Immunol. 2023 Dec 5;14:1277808. doi: 10.3389/fimmu.2023.1277808. eCollection 2023.
5
LOXL2 in Cancer: A Two-Decade Perspective.LOXL2 在癌症中的作用:二十年的研究视角。
Int J Mol Sci. 2023 Sep 21;24(18):14405. doi: 10.3390/ijms241814405.
6
Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting.LOXL2 在肝细胞癌进展中的多重作用及其作为治疗靶点的潜力。
Int J Mol Sci. 2023 Jul 21;24(14):11745. doi: 10.3390/ijms241411745.
7
TGF-β-p-STAT1-LAIR2 axis has a "self-rescue" role for exhausted CD8 T cells in hepatocellular carcinoma.TGF-β-p-STAT1-LAIR2 轴在肝癌中对耗竭的 CD8 T 细胞具有“自我拯救”作用。
Cell Oncol (Dordr). 2023 Dec;46(6):1625-1644. doi: 10.1007/s13402-023-00830-9. Epub 2023 May 24.
8
Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression.I 型胶原蛋白-DDR1 信号通过抑制 Hippo 信号促进肝癌细胞干性。
Cell Death Differ. 2023 Jul;30(7):1648-1665. doi: 10.1038/s41418-023-01166-5. Epub 2023 Apr 28.
9
Focusing on discoidin domain receptors in premalignant and malignant liver diseases.关注癌前和恶性肝脏疾病中的盘状结构域受体。
Front Oncol. 2023 Mar 15;13:1123638. doi: 10.3389/fonc.2023.1123638. eCollection 2023.
10
Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease.用于研究盘状结构域受体在肾脏疾病中作用的遗传和药理学工具。
Front Pharmacol. 2022 Sep 28;13:1001122. doi: 10.3389/fphar.2022.1001122. eCollection 2022.